Company page

Stemcyte International Ltd.

Stemcyte International Ltd. is a public company listed on the Taiwan stock exchange under the ticker 4178. The company focuses on stem cell research and therapies, aiming to advance medical treatments and improve patient outcomes. Stemcyte is dedicated to innovation in the healthcare sector, particularly in regenerative medicine.